The sixth line on the posted chart shows that interim data will be released on the Prurisol P2b trial, and that such release is projected to occur in Q3 2017. This same chart and that same information is available on the Ipix website. Lots of wailing and teeth-gnashing and angst and wild speculation here today about this projected Q3 release. Sure, I'd like to know how that trial is doing, so I'd like that release to happen. If it doesn't happen by end of this month, given that the company is still publicly advertising that this release will occur, I think Leo needs to explain the reason to Ipix shareholders. I'm not yet convinced that the interim release is not going to happen. Leo hasn't sent me a note saying that he wasn't feeling good about the whole thing.
News 
Market Data 
Discover 
